Useful materials

Current treatment regimens for type 2 diabetes in most cases are aimed at reducing sugar. This helps to control the...

Safety of Dorzagliatin in renal failure Efficacy and effect on renal function Practical application For doctors For patients Dorzagliatin as...

Dorzagliatin is an original oral glucokinase activator developed by Hua Medicine specifically for the treatment of type 2 diabetes. In...

Dorzagliatin is a modern hypoglycemic drug developed for the treatment of type 2 diabetes mellitus. Its uniqueness lies in the...

Hua Medicine is a new generation Chinese biopharmaceutical company focused on developing original therapeutic solutions for the treatment of chronic...

Current treatment of type 2 diabetes requires not only rapid reduction of glucose levels, but also long-term stability, restoration of...

Dorzagliatin (trade name-HuaTanNin®) is an innovative drug that has opened a new page in the treatment of type 2 diabetes....

Current understanding of the pathogenesis of type 2 diabetes mellitus (T2DM) requires moving away from monotherapy as a universal approach....

In 2020 , Hua Medicine and Bayer announced a strategic partnership and commercial agreement aimed at bringing the innovative drug...

Dorzagliatin is an innovative treatment for type 2 diabetes. Thisis the first drug from the group of glucokinase activators that...

Dorzagliatin is a first-in-class dual glucokinase activator approved for the treatment of type 2 diabetes. It affects two key components...

In the modern therapy of type 2 diabetes mellitus (T2DM), drugs that not only reduce glucose levels, but do it quickly,...